 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - VistaGen Therapeutics Inc. (VTGN)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-03-13 Purchase | 2019-03-14 5:22 pm | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 20,000 | $1.2644 | $25,288 | 20,000 (Indirect Direct) | View |
| 2019-11-20 Purchase | 2019-11-21 7:52 pm | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 15,000 | $0.34 | $5,100 | 15,000 (Indirect Direct) | View |
| 2020-08-21 Purchase | 2020-08-24 4:31 pm | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 30,000 | $0.69 | $20,700 | 50,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | 2013-03-24 2019-03-24 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 3,000 | $10 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | 2018-08-29 2019-03-24 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 3,000 | $1.5 | 175,000 (Direct) | View |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | 2009-12-17 2019-06-17 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 1,125 | $10 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | 2018-08-29 2019-06-17 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 1,125 | $1.5 | 175,000 (Direct) | View |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | 2011-11-01 2019-11-04 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 50,000 | $10 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | 2018-08-29 2019-11-04 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 50,000 | $1.5 | 175,000 (Direct) | View |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | 2011-12-31 2019-12-30 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 21,250 | $10 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | 2018-08-29 2019-12-30 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 21,250 | $1.5 | 175,000 (Direct) | View |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | 2015-04-25 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $10 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | 2018-08-29 2021-04-26 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $1.5 | 175,000 (Direct) | View |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | N/A 2026-06-19 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 200,000 | $3.49 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | N/A 2026-06-19 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 200,000 | $1.5 | 175,000 (Direct) | View |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | N/A 2026-11-09 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 100,000 | $3.8 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | N/A 2026-11-09 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 100,000 | $1.5 | 175,000 (Direct) | View |
| 2018-08-29 Disposition | 2018-08-31 5:28 pm | N/A 2027-04-26 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 175,000 | $1.96 | 175,000 (Direct) | View |
| 2018-08-29 Option Award | 2018-08-31 5:28 pm | N/A 2027-04-26 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 175,000 | $1.5 | 175,000 (Direct) | View |
| 2019-01-10 Option Award | 2019-01-14 9:55 pm | N/A 2029-01-10 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 25,000 | $1.74 | 25,000 (Direct) | View |
| 2019-01-14 Option Award | 2019-01-14 9:55 pm | N/A 2029-01-14 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 220,000 | $1.7 | 220,000 (Direct) | View |
| 2019-01-14 Exercise | 2019-01-15 4:29 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 21,250 | $1.5 | 0 (Direct) | View |
| 2019-01-14 Exercise | 2019-01-15 4:29 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 1,125 | $1.5 | 0 (Direct) | View |
| 2019-01-14 Exercise | 2019-01-15 4:29 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 3,000 | $1.5 | 0 (Direct) | View |
| 2019-01-14 Exercise | 2019-01-15 4:29 pm | 2018-08-29 2019-12-31 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 21,250 | $1.5 | 0 (Direct) | View |
| 2019-01-14 Exercise | 2019-01-15 4:29 pm | 2018-08-28 2019-06-17 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 1,125 | $1.5 | 0 (Direct) | View |
| 2019-01-14 Exercise | 2019-01-15 4:29 pm | 2018-08-29 2019-03-24 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 3,000 | $1.5 | 0 (Direct) | View |
| 2019-01-29 Exercise | 2019-01-30 4:05 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 375 | $1.5 | 0 (Direct) | View |
| 2019-01-29 Exercise | 2019-01-30 4:05 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 1,000 | $1.5 | 0 (Direct) | View |
| 2019-01-29 Exercise | 2019-01-30 4:05 pm | 2018-08-29 2019-03-24 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 375 | $1.5 | 0 (Direct) | View |
| 2019-01-29 Exercise | 2019-01-30 4:05 pm | 2018-08-29 2019-11-04 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 1,000 | $1.5 | 0 (Direct) | View |
| 2019-03-13 Exercise | 2019-03-14 5:12 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2,500 | $1.5 | 0 (Direct) | View |
| 2019-03-13 Exercise | 2019-03-14 5:12 pm | 2013-03-24 2019-03-24 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2,500 | $1.5 | 0 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:07 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 80,000 | $1 | 170,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:07 pm | N/A 2029-05-28 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 170,000 | $1 | 170,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:09 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $1 | 150,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:10 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 150,000 | $1 | 150,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:12 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $1 | 150,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:14 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $1 | 150,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:16 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 50,000 | $1 | 50,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:17 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 50,000 | $1 | 50,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:18 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 50,000 | $1 | 50,000 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-28 4:20 pm | N/A 2029-05-23 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 50,000 | $1 | 50,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:00 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $1.41 | 75,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:00 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 75,000 | $1.41 | 75,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:00 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 75,000 | $1.41 | 75,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 75,000 | $1.41 | 75,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $1.41 | 300,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 175,000 | $1.41 | 175,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 100,000 | $1.41 | 100,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:01 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 100,000 | $1.41 | 100,000 (Direct) | View |
| 2019-10-21 Option Award | 2019-10-22 5:02 pm | N/A 2029-10-21 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $1.41 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director | 75,000 | $0.398 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director | 75,000 | $0.398 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director | 75,000 | $0.398 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director | 75,000 | $0.398 | 75,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 300,000 | $0.398 | 300,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 150,000 | $0.398 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 150,000 | $0.398 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:10 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 150,000 | $0.398 | 150,000 (Direct) | View |
| 2020-04-23 Option Award | 2020-04-27 5:11 pm | N/A 2030-04-23 | VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP | 150,000 | $0.398 | 150,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:20 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Singh Shawn CEO | 5,000 | $0.448 | 30,375 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:28 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE CFO | 5,000 | $0.448 | 5,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:33 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER | 5,000 | $0.448 | 5,000 (Direct) | View |
| 2020-06-30 Option Award | 2020-07-01 5:35 pm | N/A N/A | VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 5,000 | $0.448 | 67,724 (Direct) | View |